Cargando…

Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma

Background: The role of ferroptosis in esophageal squamous cell carcinoma (ESCC) is still unclear. Methods: The association of iron metabolism and ferroptosis-related genes with the prognosis, copy number variation (CNV), TMB, and immune cell infiltration of ESCC was explored using data from the GEO...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Mengnan, Li, Ming, Zheng, Yuansheng, Hu, Zhengyang, Liang, Jiaqi, Bi, Guoshu, Bian, Yunyi, Sui, Qihai, Zhan, Cheng, Lin, Miao, Wang, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965120/
https://www.ncbi.nlm.nih.gov/pubmed/35371305
http://dx.doi.org/10.7150/jca.68568
_version_ 1784678364915695616
author Zhao, Mengnan
Li, Ming
Zheng, Yuansheng
Hu, Zhengyang
Liang, Jiaqi
Bi, Guoshu
Bian, Yunyi
Sui, Qihai
Zhan, Cheng
Lin, Miao
Wang, Qun
author_facet Zhao, Mengnan
Li, Ming
Zheng, Yuansheng
Hu, Zhengyang
Liang, Jiaqi
Bi, Guoshu
Bian, Yunyi
Sui, Qihai
Zhan, Cheng
Lin, Miao
Wang, Qun
author_sort Zhao, Mengnan
collection PubMed
description Background: The role of ferroptosis in esophageal squamous cell carcinoma (ESCC) is still unclear. Methods: The association of iron metabolism and ferroptosis-related genes with the prognosis, copy number variation (CNV), TMB, and immune cell infiltration of ESCC was explored using data from the GEO and TCGA database and validated by immunofluorescence in 112 ESCC patients from our center. The potential anti-cancer drugs and compounds from the GDSC and the Connectivity Map database were also screened. Results: A total of 117 iron metabolism and ferroptosis-related genes were identified. We found the expressions of PRNP, SLC3A2, SLC39A8, and SLC39A14 negatively related to the prognosis of ESCC patients, while ATP6V0A1 and LCN2 were opposite, which was validated in 112 ESCC samples from our center. And a prognostic signature was constructed based on their expressions and Cox regression coefficient (β). The low-score group exhibited a significantly worse OS. Besides, analysis of 179 ESCC samples from GSE53625 revealed that patients of poorly differentiation, more than 60 years, T4 stage, advanced N stage, advanced stage, and adjuvant therapy also exhibited a significantly shorter OS, based on which a nomogram to predict the OS was established. Moreover, the low-score group exhibited significantly higher CNV and TMB and more frequent mutations of TP53, MUC16, and NOTCH1. Higher proportion of Macrophages M2, and lower proportion of T cells follicular helper were observed in the low-score group. We discovered that AZD7762, Sunitinib, Cytarabine, Docetaxel, Vinblastine, and Elesclomol exhibited lower IC50 in the low-score group. And 20 potential compounds were identified from the CMap database. Conclusions: Six iron metabolism and ferroptosis-related genes were associated with the prognosis, CNV, TMB, and immune cell infiltration of ESCC. Some potential anti-cancer drugs and compounds may be helpful for OS.
format Online
Article
Text
id pubmed-8965120
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-89651202022-04-01 Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma Zhao, Mengnan Li, Ming Zheng, Yuansheng Hu, Zhengyang Liang, Jiaqi Bi, Guoshu Bian, Yunyi Sui, Qihai Zhan, Cheng Lin, Miao Wang, Qun J Cancer Research Paper Background: The role of ferroptosis in esophageal squamous cell carcinoma (ESCC) is still unclear. Methods: The association of iron metabolism and ferroptosis-related genes with the prognosis, copy number variation (CNV), TMB, and immune cell infiltration of ESCC was explored using data from the GEO and TCGA database and validated by immunofluorescence in 112 ESCC patients from our center. The potential anti-cancer drugs and compounds from the GDSC and the Connectivity Map database were also screened. Results: A total of 117 iron metabolism and ferroptosis-related genes were identified. We found the expressions of PRNP, SLC3A2, SLC39A8, and SLC39A14 negatively related to the prognosis of ESCC patients, while ATP6V0A1 and LCN2 were opposite, which was validated in 112 ESCC samples from our center. And a prognostic signature was constructed based on their expressions and Cox regression coefficient (β). The low-score group exhibited a significantly worse OS. Besides, analysis of 179 ESCC samples from GSE53625 revealed that patients of poorly differentiation, more than 60 years, T4 stage, advanced N stage, advanced stage, and adjuvant therapy also exhibited a significantly shorter OS, based on which a nomogram to predict the OS was established. Moreover, the low-score group exhibited significantly higher CNV and TMB and more frequent mutations of TP53, MUC16, and NOTCH1. Higher proportion of Macrophages M2, and lower proportion of T cells follicular helper were observed in the low-score group. We discovered that AZD7762, Sunitinib, Cytarabine, Docetaxel, Vinblastine, and Elesclomol exhibited lower IC50 in the low-score group. And 20 potential compounds were identified from the CMap database. Conclusions: Six iron metabolism and ferroptosis-related genes were associated with the prognosis, CNV, TMB, and immune cell infiltration of ESCC. Some potential anti-cancer drugs and compounds may be helpful for OS. Ivyspring International Publisher 2022-03-06 /pmc/articles/PMC8965120/ /pubmed/35371305 http://dx.doi.org/10.7150/jca.68568 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Zhao, Mengnan
Li, Ming
Zheng, Yuansheng
Hu, Zhengyang
Liang, Jiaqi
Bi, Guoshu
Bian, Yunyi
Sui, Qihai
Zhan, Cheng
Lin, Miao
Wang, Qun
Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
title Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
title_full Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
title_fullStr Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
title_full_unstemmed Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
title_short Identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
title_sort identification and analysis of a prognostic ferroptosis and iron-metabolism signature for esophageal squamous cell carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965120/
https://www.ncbi.nlm.nih.gov/pubmed/35371305
http://dx.doi.org/10.7150/jca.68568
work_keys_str_mv AT zhaomengnan identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma
AT liming identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma
AT zhengyuansheng identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma
AT huzhengyang identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma
AT liangjiaqi identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma
AT biguoshu identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma
AT bianyunyi identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma
AT suiqihai identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma
AT zhancheng identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma
AT linmiao identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma
AT wangqun identificationandanalysisofaprognosticferroptosisandironmetabolismsignatureforesophagealsquamouscellcarcinoma